Probiota Asia: World-leading probiotics summit comes to Asia and calls for abstracts
Probiota Asia will involve researchers, business developers and marketers, CEOs, regulators, formulators and more at the Hilton Hotel from October 11-13.
NutraIngredients-Asia Editor-in-Chief Gary Scattergood said: “I’m thrilled that we are bringing our Probiota summit, which has proved so successful in Europe and the US, here to Singapore.
“Probiota has always been about connecting science and business in probiotics and prebiotics – providing that central point of exchange – and we are excited about what we have in store our for the event later this year with our partner the International Probiotics Association.”
Researchers and those engaged in all aspects of microbiome science in academia, industry and consumer health are now being urged to submit abstracts to the scientific committee.
Gary added: “We are looking for abstracts presenting the latest state-of-the-art developments related to all aspects of prebiotic, probiotic and microbiome science relevant to human health, well-being, consumers and industry. We are particularly interested in reports from human intervention studies.
Presentations and posters
All abstracts submitted will be reviewed by the scientific committee. Successful authors will be invited to present their work either as an oral presentation or a poster at Probiota Asia.
Those whose abstracts are accepted as posters will receive a 50% discount on their registration for the conference.
Early-phase, novel, or state-of-the-art research or promising ideas covering the following topics are encouraged, including:
- Host-microbe interactions in health and disease, including preclinical and clinical studies evaluating pre- and probiotic interventions
- Application and development of “-omics” approaches in biomarker discovery, including identification of potential pre- and probiotic strains. Research identifying strain-specific effects of probiotics for health and wellbeing, including mechanism of action and bioactive discovery and isolation
- Early findings from large scale research projects and clinical trials
- Innovations and novel ideas in the areas of production processes, delivery, formulation and shelf-life
- Consumer and market insights, including population research, trends and threats, commercial packaging and marketing
- Human intervention studies
Any questions about the abstract submission process can be addressed to Dr Gemma Pearce at gemma.pearce@wrbm.com
The full abstract guidelines can be found here
Register as a delegate here
